Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer
J Clin Oncol Socinski et al. 24:4840
Publisher's Note
The October 20, 2006, article by Socinski et al titled, “Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer” (J Clin Oncol 24:4840-4847, 2006) was published online on October 18, 2006, with an error. In Table 5, 1-year survival rates were given as 29% for cisplatin/pemetrexed and 43% for carboplatin/pemetrexed, whereas it should have been 33% and 39%, respectively.
This has been corrected as of November 30, 2006.
|
